TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Binab Bio-Innovation AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
61
|
71
|
84 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
1
|
-1
|
2 |
| EBITDA |
3
|
1
|
6 |
| Total assets |
29
|
32
|
47 |
| Current assets |
20
|
22
|
34 |
| Current liabilities |
8
|
12
|
24 |
| Equity capital |
20
|
20
|
23 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
69.0%
|
62.5%
|
48.9% |
| Turnover per employee |
61
|
71
|
84 |
| Profit as a percentage of turnover |
1.6%
|
-1.4%
|
2.4% |
| Return on assets (ROA) |
6.9%
|
-3.1%
|
4.3% |
| Current ratio |
250.0%
|
183.3%
|
141.7% |
| Return on equity (ROE) |
5.0%
|
-5.0%
|
8.7% |
| Change turnover |
-11
|
-6
|
12 |
| Change turnover % |
-15%
|
-8%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.